Advertisement

Topics

Which Will Pfizer Buy? Biogen or Bristol-Myers Squibb

13:53 EST 13 Nov 2017 | Topix

Everyone has heard the talk. Pfizer is getting ready to make a deal. the skinny on Wall Street is that the U.S. pharmaceutical giant has its eyes set on rival Bristol-Myers Squibb and its immuno-oncology business.

Original Article: Which Will Pfizer Buy? Biogen or Bristol-Myers Squibb

NEXT ARTICLE

More From BioPortfolio on "Which Will Pfizer Buy? Biogen or Bristol-Myers Squibb"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...